[Table/Fig-1]:
Summary of GP’s responses to questions about fh awareness, knowledge and practice.
| AWARENESS | |
| Familiarity of FH rated as above average | 27.9% |
| Awareness about FH guidelines | 40.6% |
| Awareness about lipid specialists | 12.8% |
| KNOWLEDGE | |
| Correctly described FH | 71.4% |
| Correctly identified lipid profile | 34.6% |
| Correctly identified prevalence of FH in the community | 31.6% |
| Correctly identified the transmission rate of FH to first degree relatives | 35.3% |
| Correctly identified the CVD risk in untreated FH patients | 13.5% |
| Correctly identified that genetic testing was not required to accurately diagnose FH | 33.1% |
| Selected statins to best treat Hypercholesterolaemia | 91.7% |
| Selected a combination of statin and ezetimibe to treat severe Hypercholesterolaemia | 19.5% |
| PRACTICE | |
| Screened patients with premature CVD for FH, including screening family members | 24.8% |
| Unaware or unsure whether they had patients under their care | 41.4% |
| Performed routine family screening of patients with FH | 41.4% |
| The most prevalent age for screening young people in a kindred with FH was 13—18 years, which was selected by | 49.6% |
| Referred patients to lipid specialists | 12.8% |
| OPINIONS ON DETECTION | |
| Selected GP’s as the most effective health care provider for the early detection of FH | 84.2% |
| Selected interpretive commenting on lipid profiles to highlight patients at risk of FH | 69.2% |